These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 9848330)

  • 1. Metastasis of ovarian dysgerminoma in a postmenopausal patient: a rare case report.
    Feng Z; Zhang X; Wang P; Hu Q; Lin J
    Ann Med Surg (Lond); 2024 Aug; 86(8):4788-4792. PubMed ID: 39118733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report.
    Gashawbeza B; Dereje B; Abubeker FA
    Case Rep Obstet Gynecol; 2024; 2024():6465387. PubMed ID: 38938322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female Germ Cell Development, Functioning and Associated Adversities under Unfavorable Circumstances.
    Bharti D; Tikka M; Lee SY; Bok EY; Lee HJ; Rho GJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors.
    De Giorgi U; Casadei C; Bergamini A; Attademo L; Cormio G; Lorusso D; Pignata S; Mangili G
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31627378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study.
    Pecorelli S; Wagenaar HC; Vergote IB; Curran D; Beex LV; Wiltshaw E; Vermorken JB
    Eur J Cancer; 1999 Sep; 35(9):1331-7. PubMed ID: 10658523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.
    Carlson RW; Sikic BI; Turbow MM; Ballon SC
    J Clin Oncol; 1983 Oct; 1(10):645-51. PubMed ID: 6199468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin, vinblastine and bleomycin in advanced and relapsed germ cell tumours of ovary.
    Kumar L; Bhargawa VL; Kumar S
    Asia Oceania J Obstet Gynaecol; 1993 Jun; 19(2):133-40. PubMed ID: 7691050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternating cycles of PVB and BEP in the treatment of patients with advanced seminoma.
    Gietema JA; Willemse PH; Mulder NH; Oldhoff J; de Vries EG; Sleijfer DT
    Eur J Cancer; 1991; 27(11):1376-9. PubMed ID: 1720634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative Group.
    Pawinski A; Favalli G; Ploch E; Sahmoud T; van Oosterom AT; Pecorelli S
    Clin Oncol (R Coll Radiol); 1998; 10(5):301-5. PubMed ID: 9848330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
    Jeyakumar A; Cabeza R; Hindenburg A
    Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical treatment of ovarian malignant germ cell tumors in the adult].
    Culine S; Lhommé C; Droz JP
    Bull Cancer; 1997 Sep; 84(9):919-21. PubMed ID: 9435816
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.